Corporate governance

Committees

Audit Committee

Mr Vikas Sinha
Dr David Ebsworth
Dr Andrew Sinclair

Remuneration Committee

Dr Ken Cunningham
Dr David Ebsworth
Mr Rishi Gupta

Nominations Committee

Dr David Ebsworth
Dr Mahendra Shah
Dr Anders Ullman

Corporate social responsibility

The Board of Directors of Verona Pharma recognises the importance of sound corporate governance and strives, where practicable for a company of its size and nature, to comply with the standards of good practice prescribed by the UK Corporate Governance Code (2012) in its four specified areas:

  • Board leadership and effectiveness
  • Directors' remuneration
  • Accountibility with respect to financial practices
  • Relations with shareholders

For a copy of the UK Corporate Governance Code (2012), visit the UK Financial Reporting Council (FRC) website at www.frc.org.uk

The Board of Directors has established an Audit Committee, a Remuneration Committee and a Nominations and Corporate Governance Committee, with formally delegated duties and responsibilities.

 

Share dealing code

The Company has adopted a share dealing code in order to ensure compliance with the EU Market Abuse Regulation and Rule 21 of the AIM Rules.

Code of business conduct and ethics

The Company has adopted a code of business conduct and ethics in order to ensure compliance with the UK Bribery Act (2010) and as the Company’s “code of ethics” within the meaning of the Sarbanes-Oxley Act (2002).

AIM Rules compliance policy

The Company has adopted an AIM Rules compliance policy in order to ensure compliance with Rule 31 of the AIM Rules.

Policies and procedures for complaints

The Company has adopted policies and procedures for complaints regarding accounting, internal accounting controls, fraud and auditing matters. The Board has appointed a "compliance officer" to oversee compliance with the policies and procedures.

Financial performance

Date Title Downloads

Annual report 2016

Interim report 2016

AGM presentation 2016

Circular for placing to raise c. £44.7 million

Financial calendar

Annual General meeting

12 April 2017, 12:00pm – 6th Floor, 60 Gracechurch Street, London EC3V 0HR

Close